Galapagos NV - GLPG Company Cash Volume

Graphic logo of Galapagos (GLPG)

Development risks associated with small molecules for inflammation are driving volatility, as evidenced by the current cash position, where the metric stands at 3.53. Galapagos NV (GLPG) is aiming to regain its leadership through a team refresh and a strategic pivot toward cell therapy. Meanwhile, royalties from European sales and high liquidity ensure stability, supporting the overall financial health of the business.

GLPG - Galapagos Genomics Company Cash Position over the range 07/04/2022 - 05/08/2026

Analytical breakdowns and data insights for company Galapagos Genomics (GLPG)

- stock value and consensus price forecast:
Fundamental valuation:GLPG Galapagos
Signature product of Galapagos N.V.

This indicator measures the issuer's actual liquidity, excluding non-cash assets and accounting profits to assess the real solvency reserve. By analyzing the cash balance, an investor can determine the burn rate, which is critically important for Galapagos NV (GLPG) when financing costly CAR-T therapy developments and maintaining its strategic partnership with Gilead.

Who Galapagos NV competes with

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Company Cash on Hand ANI Pharmaceuticals, Inc. (ANIP)|Company Cash Volume MNKD|AMPH (Amphastar Corp) - Company Cash Balance|Company Cash Funds pacira.com PCRX|SPRY - Company Cash on Hand|Theravance Biopharma, Inc. - Company Cash Volume|Company Cash Balance AQST (Aquestive Therapeutics, Inc.)|SCPH: Company Cash Volume|Tectonic Therapeutic Inc. - Company Cash Balance|TNXP (Tonix Pharma) - Company Cash Volume|SXTC: Company Cash Balance|Company Cash Volume EPRX|BHST - Company Cash Reserve|eXoZymes - Company Cash on Hand|Company Cash Volume oramed.com ORMP|ENTX - Company Cash Funds|Company Liquid Assets MindWalk Holdings HYFT|ABVC: Company Cash Volume|Company Cash on Hand Cumberland Pharmaceuticals Inc.|Company Cash Funds Quantum BioPharma Limited|FGEN: Company Cash Balance|Company Cash Volume TELO|Rani Therapeutics Holdings, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Synergy CHC Corp. SNYR|Company Cash Balance RLYB|LEXX: Company Cash on Hand|Company Cash Balance PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Company Cash Funds|Company Cash on Hand Aptorum|Company Cash on Hand LYRA|Impact BioMedical Inc - Company Total Cash Volume|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance